ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05217	Basal cell carcinoma	22/327	68/7206	8.41297376957e-14
ko04550	Signaling pathways regulating pluripotency of stem cells	31/327	165/7206	7.66733244379e-12
ko04340	Hedgehog signaling pathway	16/327	58/7206	3.16317165929e-09
ko04360	Axon guidance	32/327	233/7206	1.41126965101e-08
ko05224	Breast cancer	25/327	174/7206	2.42068988192e-07
ko04950	Maturity onset diabetes of the young	10/327	29/7206	2.99258164816e-07
ko04512	ECM-receptor interaction	16/327	79/7206	3.5703364466e-07
ko05200	Pathways in cancer	48/327	492/7206	4.07397393109e-07
ko04390	Hippo signaling pathway	25/327	188/7206	1.07771673695e-06
ko04330	Notch signaling pathway	11/327	62/7206	9.02371250129e-05
ko04391	Hippo signaling pathway - fly	13/327	90/7206	0.00018937477311
ko04310	Wnt signaling pathway	20/327	181/7206	0.000189804301604
ko04916	Melanogenesis	17/327	142/7206	0.000220194910204
ko04510	Focal adhesion	24/327	240/7206	0.000222704368146
ko04392	Hippo signaling pathway -multiple species	7/327	31/7206	0.000380413183775
ko05205	Proteoglycans in cancer	25/327	271/7206	0.000815578918418
ko05202	Transcriptional misregulation in cancer	19/327	188/7206	0.000985145562509
ko04151	PI3K-Akt signaling pathway	32/327	390/7206	0.000996779641262
ko04974	Protein digestion and absorption	12/327	96/7206	0.00125529596602
ko04341	Hedgehog signaling pathway - fly	7/327	38/7206	0.00138926627961
ko00514	Other types of O-glycan biosynthesis	6/327	30/7206	0.00196379877171
ko05222	Small cell lung cancer	11/327	89/7206	0.00217407043248
ko04514	Cell adhesion molecules (CAMs)	14/327	130/7206	0.00219958461588
ko04072	Phospholipase D signaling pathway	1/327	197/7206	0.00246812015809
ko04932	Non-alcoholic fatty liver disease (NAFLD)	1/327	182/7206	0.00335838660797
ko04020	Calcium signaling pathway	3/327	265/7206	0.00368637749126
ko04921	Oxytocin signaling pathway	2/327	209/7206	0.006243999576
ko03410	Base excision repair	6/327	38/7206	0.00673216326374
ko05203	Viral carcinogenesis	4/327	277/7206	0.00744649580569
ko05010	Alzheimer's disease	2/327	202/7206	0.00896949581996
ko05166	HTLV-I infection	23/327	292/7206	0.00905762459928
ko04080	Neuroactive ligand-receptor interaction	9/327	423/7206	0.0110117621889
ko00350	Tyrosine metabolism	5/327	33/7206	0.0155560740808
ko05168	Herpes simplex infection	2/327	182/7206	0.0177050105045
ko04723	Retrograde endocannabinoid signaling	2/327	175/7206	0.0251952136399
ko00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	4/327	26/7206	0.0282492159753
ko00190	Oxidative phosphorylation	1/327	127/7206	0.030966097031
ko04611	Platelet activation	2/327	163/7206	0.0348269451917
ko03013	RNA transport	2/327	166/7206	0.0353306280607
ko00230	Purine metabolism	3/327	194/7206	0.0357265374975
ko04062	Chemokine signaling pathway	3/327	201/7206	0.0366018254609
ko00830	Retinol metabolism	5/327	42/7206	0.0401216993626
ko04912	GnRH signaling pathway	1/327	122/7206	0.0450525238449
ko04724	Glutamatergic synapse	2/327	152/7206	0.0485537999044
ko04621	NOD-like receptor signaling pathway	2/327	157/7206	0.0493695519999